Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
27.5M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
16M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$101M
-
Value change
-
+$7.28M
-
Number of buys
-
37
-
Number of sells
-
-24
-
Price
-
$6.32
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2024
75 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value as of Q4 2024.
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16M shares
of 27.5M outstanding shares and own 58.46% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4.08M shares), Sonic GP LLC (2.41M shares), Solas Capital Management, LLC (2.25M shares), Rosalind Advisors, Inc. (1.26M shares), BlackRock, Inc. (1.23M shares), DG Capital Management, LLC (1.11M shares), VANGUARD GROUP INC (970K shares), HARBERT FUND ADVISORS, INC. (467K shares), MORGAN STANLEY (346K shares), and STATE STREET CORP (340K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.